| Application no. and date | 23172794.2 (espacenet) (Federated) (European Patent Register), 20121011 | | Patent/reg. no. and date | DK/EP 4234033, 20250129 | | Publication date | 20230830 | | Priority no. and date | US 201161547535 P, 20111014, US 201161567015 P, 20111205, US 201261657669 P, 20120608, US 201261682037 P, 20120810, US 201261694584 P, 20120829 | | EP pub. no. and date |
EP 4234033 20230830 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P86124DK01 | | Inventor | ALAVATTAM, Sreedhara,
South San Francisco, 94080, US,
AMLER, Lukas C.,
South San Francisco, US,
BENYUNES, Mark C.,
South San Francisco, 94080, US,
CLARK, Emma I.,
Welwyn Garden City, AL7 1TW, GB,
DE TOLEDO PELIZON, Christina H.,
4070 Basel, CH,
KWONG GLOVER, Zephania W.,
South San Francisco, 94080, US,
MITCHELL, Lada,
4070 Basel, CH,
RATNAYAKE, Jayantha,
Welwyn Garden City, AL7 1TW, GB,
ROSS, Graham A.,
Welwyn Garden City, AL7 1TW, GB,
WALKER, Ru-Amir,
South San Francisco, 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 16/32 (2006.01) | | Title | Anvendelser for og fremstillet artikel indbefattende HER2-dimeriseringshæmmeren pertuzumab | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
